You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Temodar

Showing 1 - 25 of 314
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

Not yet recruiting
  • Recurrent High Grade Glioma
  • +4 more
  • (no location specified)
Jan 24, 2023

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Glioblastoma Trial in Milwaukee (Radiation, Concurrent Chemotherapy (Temozolomide), Adjuvant Chemotherapy (Temozolomide))

Recruiting
  • Glioblastoma
  • Radiation
  • +2 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Jul 25, 2022

Glioblastoma Trial in Louisville (Pembrolizumab and Temozolomide)

Recruiting
  • Glioblastoma
  • Pembrolizumab and Temozolomide
  • Louisville, Kentucky
    James Graham Brown Cancer Ctr.
Jan 18, 2023

Ovarian Aging in Low Grade Glioma Treated With Temozolomide

Terminated
Has Results
  • Low Grade Glioma
    • San Francisco, California
      UCSF Center for Reproductive Health
    Jul 6, 2022

    Ewing Sarcoma Trial in Beijing (Vincristine, Temozolomide)

    Recruiting
    • Ewing Sarcoma
    • Beijing, Beijing, China
      Peking University People's Hospital
    Oct 31, 2022

    Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

    Active, not recruiting
    • Glioblastoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jan 30, 2023

    Glioblastoma, Recurrent Glioblastoma Trial in Boston (Pembrolizumab, Olaparib, Temozolomide)

    Not yet recruiting
    • Glioblastoma
    • Recurrent Glioblastoma
    • Boston, Massachusetts
    • +2 more
    Jul 14, 2022

    Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)

    Recruiting
    • Anaplastic Oligoastrocytoma
    • Glioblastoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 27, 2022

    Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

    Recruiting
    • Glioblastoma, IDH-wildtype
    • +4 more
    • Eflornithine (Dose Level 1)
    • +3 more
    • Cleveland, Ohio
      The Cleveland Clinic
    May 19, 2023

    Non Small Cell Lung Cancer, CNS Progression Trial in Aurora (Temozolomide plus Osimertinib, Temozolomide plus Lorlatinib)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • CNS Progression
    • Temozolomide plus Osimertinib
    • Temozolomide plus Lorlatinib
    • Aurora, Colorado
      University of Colorado Hospital
    May 12, 2022

    Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV) Trial in Baltimore (Chemotherapy with Temodar.,

    Terminated
    Has Results
    • Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)
    • Chemotherapy with Temodar.
    • Radiation therapy
    • Baltimore, Maryland
      Ummc Msgcc
    Dec 1, 2022

    Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)

    Active, not recruiting
    • Malignant Supratentorial Neoplasm
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2021

    Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)

    Recruiting
    • Relapsed Neuroblastoma
    • Refractory Neuroblastoma
    • Natural Killer Cells
    • +4 more
    • Columbus, Ohio
      Nationwide Children's Hospital
    Oct 26, 2022

    Melanoma (Skin) Trial in Philadelphia (sorafenib tosylate, temozolomide)

    Completed
    Has Results
    • Melanoma (Skin)
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jun 13, 2022

    Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

    Not yet recruiting
    • Rhabdomyosarcoma
    • Palo Alto, California
    • +2 more
    Aug 27, 2023

    Solid Tumors, Neuroblastoma, Rhabdomyosarcoma Trial in Durham, Cincinnati (VAL-413, Temozolomide)

    Recruiting
    • Solid Tumors
    • +5 more
    • Durham, North Carolina
    • +2 more
    Jan 31, 2023

    Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

    Active, not recruiting
    • Glioblastoma
    • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Nov 16, 2022

    Glioblastoma Multiforme Trial in Saint Louis (drug, procedure, radiation)

    Active, not recruiting
    • Glioblastoma Multiforme
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 22, 2022

    Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))

    Recruiting
    • Colorectal Neoplasms
    • Microsatellite Instability
    • temozolomide (induction),
    • pembrolizumab (treatment)
    • Milano, Italy
    • +3 more
    Sep 28, 2022

    Glioblastoma Multiforme Trial in Iowa City (Chlorpromazine, Temozolomide, Radiation Therapy)

    Recruiting
    • Glioblastoma Multiforme
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics
    Mar 1, 2022

    Brain Tumors by Advanced MRI

    Completed
    • Glioblastoma
    • Avastin
    • +5 more
    • Boston, Massachusetts
      Massachusetts general Hospital
    Apr 6, 2022

    Glioblastoma (GBM) Trial in Phoenix (dietary supplement, radiation, drug)

    Terminated
    • Glioblastoma (GBM)
    • Ketogenic Diet
    • +2 more
    • Phoenix, Arizona
      Barrow Neurological Institute at St. Joseph's Hospital and Medic
    Jun 11, 2021

    Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)

    Completed
    • Metastatic Cancer
    • Unspecified Adult Solid Tumor
    • PARP inhibitor BMN-673
    • +4 more
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Sep 22, 2022

    Malignant Glioma of Brain Trial in Chicago (Acetazolamide, Temozolomide)

    Recruiting
    • Malignant Glioma of Brain
    • Chicago, Illinois
      University of Chicago Medical Center
    Apr 1, 2022